땅콩 알레르기 치료 시장 규모, 점유율 및 성장 분석 : 치료법별, 환자층별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Peanut Allergy Treatment Market size was valued at USD 536.8 Million in 2024 and is poised to grow from USD 598.16 Million in 2025 to USD 1421.78 Million by 2033, growing at a CAGR of 11.43% during the forecast period (2026-2033).

The global peanut allergy treatment market is primarily driven by the significant unmet clinical need and the increasing prevalence of the condition, coupled with a growing demand for proactive treatment approaches rather than mere avoidance. Comprising pharmaceuticals, biologics, diagnostics, and clinical models, this market facilitates precise diagnosis and effective management through graduated desensitization. The shift from traditional avoidance strategies to innovative therapies like oral immunotherapy has spurred substantial investment and regulatory support, enhancing treatment accessibility. Moreover, reimbursement policies and clinical acceptance are crucial in fostering market growth. Additionally, AI plays a transformative role in personalizing treatments by analyzing complex patient data to identify subtypes, optimize dosing, and enhance safety, thereby driving investment and innovation across the sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Peanut Allergy Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Peanut Allergy Treatment Market Segments Analysis

Global peanut allergy treatment market is segmented by treatment modality, patient demographic, end-user and region. Based on treatment modality, the market is segmented into Oral Immunotherapy (OIT), Sublingual Immunotherapy (SLIT), Epicutaneous Immunotherapy (EPIT), Targeted Biologics and Monoclonal Antibodies and Others. Based on patient demographic, the market is segmented into Pediatric (Ages 4 to 17) and Adult (Ages 18 and Above). Based on end-user, the market is segmented into Hospitals and Allergy Centers, Specialized Immunology Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Peanut Allergy Treatment Market

The rising prevalence of peanut allergies is driving the demand for effective treatment options, prompting pharmaceutical and biotech companies to focus on research and development efforts. As more individuals are diagnosed, healthcare providers and caregivers are becoming increasingly aware of the condition, which facilitates earlier detection and improved long-term management strategies emphasizing therapeutic interventions. This growing need not only underscores the urgency for innovative solutions but also encourages investment in novel immunotherapies and supplementary treatments. Consequently, there is an expansion of development initiatives and heightened commercial interest within the industry, as stakeholders aim to address the needs of this expanding patient population.

Restraints in the Global Peanut Allergy Treatment Market

The global peanut allergy treatment market faces significant constraints due to the considerable financial investment needed for extensive research, intricate clinical trials, and specialized manufacturing processes. These requirements create high entry barriers that deter smaller companies from participating, thereby limiting the diversity of market players. Furthermore, the lengthy timelines and unpredictable returns on investment lead organizations to favor safer, lower-risk initiatives, which can hinder the introduction of new products. Additionally, the perception of high treatment costs can impact payer coverage decisions and clinicians' prescribing practices, fostering caution among various stakeholders and ultimately slowing broader adoption despite existing clinical demand, affecting the long-term viability of the market.

Market Trends of the Global Peanut Allergy Treatment Market

The Global Peanut Allergy Treatment market is witnessing a notable shift towards patient-centric therapeutic pathways, placing a heightened focus on enhancing convenience, safety, and quality of life for sufferers. This trend drives innovation in home-based administration options, bolstered by improved patient education, digital adherence tools, and comprehensive caregiver support. Additionally, clinical development increasingly prioritizes patient-reported outcomes and flexible visit schedules, aligning with stakeholder interests in shared decision-making and personalized treatment plans. Payors and health systems are actively exploring care models that minimize disruptions for patients, fostering disease management strategies tailored to individual lifestyles and preferences, ultimately reshaping the landscape of peanut allergy interventions.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Peanut Allergy Treatment Market Size by Treatment Modality & CAGR (2026-2033)

• Market Overview
• Oral Immunotherapy (OIT)
• Sublingual Immunotherapy (SLIT)
• Epicutaneous Immunotherapy (EPIT)
• Targeted Biologics and Monoclonal Antibodies
• Others

Global Peanut Allergy Treatment Market Size by Patient Demographic & CAGR (2026-2033)

• Market Overview
• Pediatric (Ages 4 to 17)
• Adult (Ages 18 and Above)

Global Peanut Allergy Treatment Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals and Allergy Centers
• Specialized Immunology Clinics
• Others

Global Peanut Allergy Treatment Market Size & CAGR (2026-2033)

• North America (Treatment Modality, Patient Demographic, End-User)
  • US
  • Canada
• Europe (Treatment Modality, Patient Demographic, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Treatment Modality, Patient Demographic, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Treatment Modality, Patient Demographic, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Treatment Modality, Patient Demographic, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Nestle
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aravive
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dbv Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prota Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Camallergy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intrommune Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergy Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regeneron Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stallergenes Greer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aimmune Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HAL Allergy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Desensitization Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cour Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AnaptysBio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siolta Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InnoUp Farma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations